A Randomized Controlled Trial of the Launching! to Adulthood Program

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine whether the Launching intervention leads to improvements in executive functioning, co-occurring mental health symptoms, and quality of life, as measured by caregiver and self-report assessments, to assess the maintenance of treatment gains 12 weeks post-treatment and to replicate the findings of the Launching pilot study in an independent sample of young adults with ASD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 25
Healthy Volunteers: f
View:

• confirmed case of ASD from a licensed mental health or medical professional

• score of \>14 on the Social Communication Questionnaire-Lifetime (SCQ-L) completed with the mother or father

• meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ASD symptom checklist

• willing and motivated to participate in the treatment

• a parent willing to participate

• verbal intelligence quotient (IQ) score \>70 as assessed by the Kaufman Brief Intelligence Test 2nd edition revised (KBIT-2-R)

Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Antonio Pagan, PhD
Antonio.Pagan@uth.tmc.edu
(713) 486-2700
Backup
Katherine Loveland, PhD
Katherine.A.Loveland@uth.tmc.edu
(713) 486-2587
Time Frame
Start Date: 2025-07-15
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 40
Treatments
Experimental: Launching! to adulthood group therapy
Active_comparator: No intervention then Launching! to adulthood group therapy
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston

This content was sourced from clinicaltrials.gov